Physician profile
Maria E Jacquez
NPI 1518290964
$8,660.64
in general payments reported to CMS, 2019-2025
44 companies · $1,273 in 2025
The $1,273 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,768 · 2022: $2,175 · 2023: $1,102 · 2024: $1,342 · 2025: $1,273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,717.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $916.61 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $851.76 | 2021-2025 | |
| Novo Nordisk INC | $675.75 | 2021-2025 | Ozempic, Rybelsus |
| Dexcom, INC. | $536.49 | 2021-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $525.57 | 2021-2025 | Farxiga, Lokelma, Airsupra |
| Amgen INC. | $498.98 | 2021-2025 | Repatha, Otezla, Otezla |
| Glaxosmithkline, LLC. | $497.13 | 2021-2025 | Nucala, Trelegy Ellipta, Shingrix |
| Abbvie INC. | $475.39 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $354.82 | 2021-2025 | Jardiance |
| Pfizer INC. | $348.20 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $290.46 | 2021-2024 | Xarelto |
| Amarin Pharma, INC. | $233.29 | 2021-2022 | |
| Medtronic, INC. | $229.36 | 2022-2025 | Endurant Iis, Minimed 780g, Heli-Fx Endoanchor System |
| Mylan Specialty L.P. | $178.07 | 2021-2022 | |
| Radius Health, INC. | $176.33 | 2022-2025 | Tymlos |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Jacquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.